Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts-Reference-Cited by-同舟云学术

Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts

Published:2014-11-24 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Ziouèche-Mottet Amira,Houvenaeghel Gilles,Classe Jean Marc,Garbay Jean Rémi,Giard Sylvia,Charitansky Hélène,Cohen Monique,Belichard Catherine,Faure Christelle,Chéreau Ewald Elisabeth,Hudry Delphine,Azuar Pierre,Villet Richard,Gimbergues Pierre,Tunon de Lara Christine,Tallet Agnès,Bannier Marie,Minsat Mathieu,Lambaudie Eric,Resbeut Michel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-868.pdf

Reference21 articles.

1. GLOBOCAN: Incidence et mortalité du cancer dans le monde. 2008, http://globocan.iarc.fr/ ,

2. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011, 378 (9804): 1707-1716.

3. Cowen D, Jacquemier J, Houvenaeghel G, Viens P, Puig B, Bardou VJ, Resbeut M, Maraninchi D: Local and distant recurrence after conservative management of “very low-risk” breast cancer are dependent events: a 10-year follow-up. Int J Radiat Oncol Biol Phys. 1998, 41 (4): 801-807. 10.1016/S0360-3016(98)00144-8.

4. Vaidya JS, Baum M, Tobias JS, Wenz F, Massarut S, Keshtgar M, Hilaris B, Saunders C, Williams NR, Brew-Graves C, Corica T, Roncadin M, Kraus-Tiefenbacher U, Sütterlin M, Bulsara M, Joseph D: Long-term results of targeted intraoperative radiotherapy Targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2011, 81 (4): 1091-1097. 10.1016/j.ijrobp.2010.07.1996.

5. Vaidya JS, Baum M, Tobias JS, Wenz F, Massarut S, Keshtgar M, Hilaris B, Saunders C, Williams NR, Brew-Graves C, Corica T, Roncadin M, Kraus-Tiefenbacher U, Sütterlin M, Bulsara M, Joseph D: Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010, 376 (9735): 91-102. 10.1016/S0140-6736(10)60837-9.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems;Frontiers in Oncology;2022-08-11

2. Intraoperative Radiotherapy for Breast Cancer in Elderly Women;Clinical Breast Cancer;2022-01

3. Intraoperative Radiotherapy Is Not a Better Alternative to Whole Breast Radiotherapy as a Therapeutic Option for Early-Stage Breast Cancer;Frontiers in Oncology;2021-12-16

4. Margin assessment before intraoperative radiotherapy during breast conserving surgery—Does the addition of MarginProbe decrease the need for addition of fractionated whole breast radiation?;The Breast Journal;2020-05-04

5. Contribution of intraoperative radiotherapy (IORT) for therapeutic de-escalation in early breast cancer: Report of a single institution's experience;The Breast Journal;2018-01-22